Home › Brain Diseases › Virginia
Brain Diseases clinical trials in Virginia
4 studies for Brain Diseases are looking for participants at sites in Virginia.
Cities in Virginia
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Re:Cognition Health, Fairfax
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #066, Arlington
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Virginia Cancer Institute, Norfolk
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05386108Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Fairfax
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.